Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1280.37x is 16% above its 5-year average of -1532.11x, around the middle of its 5-year range (-3822.70x–-128.52x).
2.39% below its 12-month average of -1250.45x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -481.53x.
INTEREST COVERAGE RATIO
-1280.37x
INTEREST COVERAGE RATIO AVG TTM
-1250.45x
INTEREST COVERAGE RATIO AVG 3Y
-1790.61x
INTEREST COVERAGE RATIO AVG 5Y
-1532.11x
INTEREST COVERAGE RATIO AVG 10Y
-1197.33x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-2.39%
CURRENT VS 3Y AVG
+28.50%
CURRENT VS 5Y AVG
+16.43%
CURRENT VS 10Y AVG
-6.94%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.39x
median of 425 covered companies
CURRENT VS SECTOR MEDIAN
-23654.55%
vs the sector median at left
InflaRx N.V.
Market Cap
$242.30M
Interest Coverage Ratio
-1280.37x
TTM Avg
-1250.45x
3Y Avg
-1790.61x
5Y Avg
-1532.11x
Market Cap
$243.67M
Interest Coverage Ratio
-2.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.34M
Interest Coverage Ratio
0.97x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$243.48M
Interest Coverage Ratio
0.57x
TTM Avg
0.57x
3Y Avg
0.57x
5Y Avg
0.57x
Market Cap
$245.38M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$240.31M
Interest Coverage Ratio
N/A
TTM Avg
0.97x
3Y Avg
1.45x
5Y Avg
67.07x
Market Cap
$237.69M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
Market Cap
$237.40M
Interest Coverage Ratio
-133.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InflaRx N.V. (IFRX) | $242.30M | -1280.37x | -1250.45x | -1790.61x | -1532.11x |
| Galectin Therapeutics Inc. (GALT)vs › | $243.67M | -2.74x | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $242.34M | 0.97x | 0.97x | 0.97x | 0.97x |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.48M | 0.57x | 0.57x | 0.57x | 0.57x |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $245.38M | N/A | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.31M | N/A | 0.97x | 1.45x | 67.07x |
| High Tide Inc. (HITI)vs › | $237.69M | -1.08x | 0.39x | 0.39x | 0.20x |
| BioAge Labs Inc. (BIOA)vs › | $237.40M | -133.11x | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $248.32M | N/A | N/A | N/A | N/A |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $248.50M | N/A | N/A | N/A | N/A |
Interest Coverage
-1280.4x
Debt/Equity
0.01
Current Ratio
8.22
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -481.53x |
| 2026-03-31 | -478.88x |
| 2025-12-31 | -809.12x |
| 2025-09-30 | -660.00x |
| 2025-06-30 | -3822.70x |
| 2025-03-31 | -3182.85x |
| 2024-12-31 | -2042.99x |
| 2024-09-30 | -3052.47x |
| 2024-06-30 | -1763.25x |
| 2024-03-31 | -2484.32x |
| 2023-12-31 | -614.01x |
| 2023-09-30 | -2093.22x |
| 2023-06-30 | -1792.58x |
| 2023-03-31 | -1786.28x |
| 2022-12-31 | -1284.82x |
| 2022-09-30 | -1247.17x |
| 2022-06-30 | -128.52x |
| 2022-03-31 | -538.72x |
| 2021-12-31 | -1336.35x |
| 2021-09-30 | -1133.90x |
| 2021-06-30 | -1440.67x |
| 2021-03-31 | -1785.83x |
| 2020-12-31 | -109.28x |
| 2020-06-30 | -42.85x |
| 2020-03-31 | -4552.57x |
| 2019-09-30 | -3145.68x |
| 2019-06-30 | -1804.54x |
| 2019-03-31 | -1203.84x |
| 2018-12-31 | -659.84x |
| 2017-09-30 | -3.92x |
| 2017-06-30 | -4.55x |
| 2016-09-30 | -2.55x |
| 2016-06-30 | -2.74x |
